Remifentanil's effect is not prolonged in a patient with pseudocholinesterase deficiency

被引:18
作者
Manullang, J [1 ]
Egan, TD [1 ]
机构
[1] Univ Utah, Hlth Sci Ctr, Dept Anesthesiol, Salt Lake City, UT 84132 USA
关键词
D O I
10.1097/00000539-199908000-00053
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
[No abstract available]
引用
收藏
页码:529 / 530
页数:2
相关论文
共 8 条
[1]   METABOLISM AND URINARY-EXCRETION OF ESMOLOL IN HUMANS [J].
ACHARI, R ;
DRISSEL, D ;
MATIER, WL ;
HULSE, JD .
JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (01) :44-47
[2]   Cholinesterase - Its significance in anaesthetic practice [J].
Davis, L ;
Britten, JJ ;
Morgan, M .
ANAESTHESIA, 1997, 52 (03) :244-260
[3]   REMIFENTANIL PHARMACOKINETICS AND PHARMACODYNAMICS - A PRELIMINARY APPRAISAL [J].
EGAN, TD .
CLINICAL PHARMACOKINETICS, 1995, 29 (02) :80-94
[4]   PLASMA CHOLINESTERASE - GENE AND VARIATIONS [J].
PANTUCK, EJ .
ANESTHESIA AND ANALGESIA, 1993, 77 (02) :380-386
[5]  
PETERSEN RS, 1993, ANESTH ANALG, V76, P194
[6]  
ROSOW C, 1993, ANESTHESIOLOGY, V79, P875
[7]   Remifentanil [J].
Smith, MA ;
Morgan, M .
ANAESTHESIA, 1997, 52 (04) :291-293
[8]   Remifentanil - An opioid for the 21st century [J].
Thompson, JP ;
Rowbotham, DJ .
BRITISH JOURNAL OF ANAESTHESIA, 1996, 76 (03) :341-343